Bremelanotide for Female Sexual Dysfunctions Responder Analyses From a Phase 2B Dose-Ranging Study

被引：5
|
作者：
DeRogatis, Leonard R. [1 ]
Edelson, Jeffrey [1 ]
Jordan, Robert [1 ]
Greenberg, Sally [1 ]
Portman, David J. [1 ]
机构：
[1] Maryland Ctr Sexual Hlth, Lutherville Timonium, MD USA
来源：
OBSTETRICS AND GYNECOLOGY | 2014年 / 123卷
关键词：
D O I：
10.1097/01.AOG.0000447289.23270.72
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：26S / 27S
页数：2
相关论文
共 50 条
  • [1] Responder Analyses from a Phase 2b Dose-Ranging Study of Bremelanotide
    Althof, Stanley
    Derogatis, Leonard R.
    Greenberg, Sally
    Clayton, Anita H.
    Jordan, Robert
    Lucas, Johna
    Spana, Carl
    JOURNAL OF SEXUAL MEDICINE, 2019, 16 (08): : 1226 - 1235
  • [2] Bremelanotide for Hypoactive Sexual Desire Disorder: Analyses From a Phase 2B Dose-Ranging Study
    Portman, David J.
    Edelson, Jeffrey
    Jordan, Robert
    Clayton, Anita
    Krychman, Michael L.
    OBSTETRICS AND GYNECOLOGY, 2014, 123 : 31S - 31S
  • [3] BREMELANOTIDE FOR HYPOACTIVE SEXUAL DESIRE DISORDER: ANALYSES FROM A PHASE 2B DOSE-RANGING STUDY
    Kingsberg, S.
    Jordan, R.
    Clayton, A.
    Krychman, M.
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 389 - 389
  • [4] Distress Reduction in Female Sexual Dysfunctions A Dose-Ranging Study of Subcutaneous Bremelanotide
    Kingsberg, Sheryl
    DeRogatis, Leonard R.
    Edelson, Jeffrey
    Jordan, Robert
    Krychman, Michael L.
    OBSTETRICS AND GYNECOLOGY, 2014, 123 : 29S - 30S
  • [5] Phase 2b bremelanotide study in premenopausal and postmenopausal women with female sexual arousal disorder
    Levine, Stephen B.
    Brown, Candace
    Palace, Eileen
    Fischkoff, Steven
    Schnorrbusch, Christine
    OBSTETRICS AND GYNECOLOGY, 2008, 111 (04): : 85S - 85S
  • [6] Subcutaneous Bremelanotide for Female Sexual Dysfunctions in Premenopausal Women: Responder Analyses Based on Receiver Operating Characteristics Curves
    Rosen, Raymond
    Edelson, Jeffrey
    Jordan, Robert
    Greenberg, Sally
    DeRogatis, Leonard
    Portman, David
    REPRODUCTIVE SCIENCES, 2014, 21 (03) : 212A - 212A
  • [7] IMPROVEMENT IN SEXUAL FUNCTION AS MEASURED BY THE FEMALE SEXUAL FUNCTION INDEX IN PREMENOPAUSAL WOMEN DURING A 12-WEEK PLACEBO-CONTROLLED DOSE-RANGING STUDY OF SELF-ADMINISTERED SUBCUTANEOUS BREMELANOTIDE FOR FEMALE SEXUAL DYSFUNCTIONS
    Krychman, M.
    Edelson, J.
    Jordan, R.
    Rosen, R.
    JOURNAL OF SEXUAL MEDICINE, 2014, 11 : 18 - 18
  • [8] Bimekizumab treatment response is maintained up to 3 years in patients with psoriatic arthritis: Responder analyses from BE ACTIVE, a phase 2b dose-ranging study, and its open-label extension
    Merola, Joseph F.
    Asahina, Akihiko
    Ritchlin, Christopher T.
    Ink, Barbara
    Assudani, Deepak
    Bajracharya, Rajan
    Coarse, Jason
    Eells, Jason
    Mease, Philip J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB146 - AB146
  • [9] Efficacy of Subcutaneous Bremelanotide Self-Administered at Home by Premenopausal Women with Female Sexual Dysfunction: A Placebo-Controlled Dose-Ranging Study
    Portman, David
    Clayton, Anita
    Jordan, Robert
    Edelson, Jeffrey
    Greenberg, Sally
    DeRogatis, Leonard
    Kingsberg, Sheryl
    Rosen, Raymond
    Althof, Stanley
    Krychman, Michael
    REPRODUCTIVE SCIENCES, 2014, 21 (03) : 119A - 120A
  • [10] EFFICACY OF SUBCUTANEOUS BREMELANOTIDE SELF-ADMINISTERED AT HOME BY PREMENOPAUSAL WOMEN WITH FEMALE SEXUAL DYSFUNCTION: A PLACEBO-CONTROLLED DOSE-RANGING STUDY
    Jordan, Robert
    Edelson, Jeffrey
    Greenberg, Sally
    DeRogatis, Leonard R.
    Kingsberg, Sheryl
    Rosen, Raymond
    Althof, Stanley E.
    Clayton, Anita
    Portman, David J.
    Krychman, Michael L.
    JOURNAL OF SEXUAL MEDICINE, 2013, 10 : 178 - 178
12345